SlideShare a Scribd company logo
The 2004 AASLD Annual
      Meeting Speaker Disclosure
                Slide


I have no conflict of interest
The Methyl Trasnferase PRMT1 Functions As Co-
      Activator of FXR/RXR and Regulates
     Transcription of FXR Responsive Gene In
                   Hepatocytes.

Stefano Fiorucci1, Giovanni Rizzo1, Barbara Renga1,
    Elisabetta Antonelli1, Eleonora Distrutti1, Mark
  Pruzanski2; Antonio Morelli1, Roberto Pellicciari3

           1
             Departement of Internal Medicine,
            Gastrointestinal and Liver Unit and
             3
               Department of Drug Technology,
                 University of Perugia, Italy
        2
          Intercept Pharmaceuticals, New York, NY
FARNESOID X RECEPTOR (FXR)
FXR is a ligand
                                                Role of FXR in bile acid biosynthesis
 activated NR that
 regulates bile acid
 synthesis and
 excretion and lipid
 homeostasis
FXR is expressed in
 liver,kidney and
 intestine
Target genes:
 CYP7A1, SHP,
 BSEP, MRP2,
 MDR3, I-BABP
                Mikishima M., et al. Science 1999; 284: 1362-65; Parks DJ., et al. Science 1999; 284: 1365-68
                                        Goodwin B., et al. Molecular cell 2000; 6: 507-515
Background

 FXR is an obligate partner of nuclear
    RXR (Retinoid X Receptor)

 In the presence of FXR ligands, the
FXR/RXR complex recruits members
  of the p160 coactivator family that
          acetylate histones
Background
      In addition to acetylation, histone methylation
     is critically involved in chromatin remodelling in
                        eukaryotic cells

      PRMT(Protein aRginine MethylTransferase)-1
         is the predominant, if not exclusive, H4
       Arg3-methyltransferase in mammalian cells

          PRMT1 functions as a coactivator for NRs
         (thyroid, estrogen and androgen receptors..)


Kouzarides T. Current Opinion in Genetics & Develop 2002; 12: 198-209
FXR Crystal Structure In Complex
          With 6-ECDCA
                                                        CO2H

     FXR -LBD                                       H

                                                                                                     GW4064
                                                                                                     6-ECDCA
                                                                                              150
                                                               +




                                                                   Relative Luciferase/βGal
                                                                                                     CDCA
                           HO                OH          π
                                                                                              100



                                                                                               50



                                                                                                0
                                                                                                    -10   -9   -8   -7   -6   -5   -4
                                                                                                    Agonist concentration (Log M)



            6-
            ECDCA

Mi L-Z., et al. Molecular Cell 2003; 11:1093-1100
Aims

    Activation of FXR/RXR complex
           recruits PRMT1


PRMT1 mediates the effects of FXR/RXR
        ligands on target genes
Results
FXR/RXR activation
leasds to methylation of Histone 4
In vitro methylation

293T cells (kidney fibroblast) were transiently
   transfected with FXR, RXR and PRMT1
     expression vectors and then induced
                with FXR ligands
     Cell lysates were Immunoprecipitated
             with anti-FXR antiboby.
 The immunoprecipitated were then used for
 in vitro methylation by incubating them with
        methyl 3H-methionine followed by
           SDS page and fluorography
FXR/RXR posses H4 specific histone methylation activity



              6-ECDCA     -         +         -    -       +   +               +

 In vitro       H4
methylation
                                                                      GST-      IP:
              IP anti-:       PAS         CD3 FXR CD3 FXR
                                                                     PRMT1   anti-FXR




                                                       -       +   6-ECDCA
                               WB: anti FXR

                               WB: anti RXR
                                                  WT
                                                       FXR/RXR
Is FXR/RXR-induced histone
   methylation mediated
        by PRMT1?
FXR Interacts In Vivo With PRMT1

 6-ECDCA            +       +       -             +        -
                                                                   WB: PRMT1
                                                                    (42 KDa)

                 IP:          IP:
                αCD3        α FXR                     LT              293T cells
                                                                   FXR/RXR/PRMT1




GW4064     +            -   +           -              +       -
                                                                       WB: PRMT1
                                                                        (42 KDa)
                                            Mks
                              IP:                            IP:
               LT
                            α CD3                          α FXR           293T cells
                                                                        FXR/RXR/PRMT1
HepG2 cells

                                                             PRMT1 Functions As A Coactivator of
                                                                  FXR/RXR Heterodimer


             4000000       DMSO
                           6-ECDCA         *                               150000                     FXR/RXR/PRMT1
                                                                                                  *
             3000000
Rlu/ β Gal




                                               FXRE-Mut                    100000




                                                               rlu/β-gal
             2000000
                                                                                             *
                                     *               **                                               FXR/RXR
             1000000                                                        50000


                   0
                                                                                0
                       PRMT1   FXR/RXR   FXR/RXR/PRMT1
                                                                                    0   0.1   1    10 100
                                                                                           6-ECDCA (µM)
PRMT1 Induces Transcriptional Activation
              of BSEP




         FXR/RXR       FXR/RXR/PRMT1
PRMT1 Induces Transcriptional Activation
              of SHP




            FXR/RXR    FXR/RXR/PRMT1
PRMT1 Enhances FXR Activation of The
       BSEP Promoter by H4 Methylation

   Immunochromatin precipitation (ChIP) was used to analyze
    the promotorial context of FXR responsive gene promoter
      in HepG2 cells cotransfected with FXR, RXR, PRMT1
                       expression vectors

       ChIPs was performed with anti: FXR, PRMT1, dimethyl-
       H4 (Arg3) and CytC. Immunoprecipitates were analyzed
          by qRT-PCR to BSEP gene promoter (binds FXR)*




Ananthanarayanan M., et al., JBC 2001:276:28857
PRMT1 ENHANCES FXR ACTIVATION OF THE BSEP PROMOTER BY
                   H4 METHYLATION.


                      -         +   -   +   -    +   -      +   6-ECDCA
   BSEP Promoter
                                            Met-H4
          IP anti:        FXR       PRMT1                CytC
                                            (Arg3)




                                                                  HepG2 cells
                                                                FXR/RXR/PRMT1




               IP anti: FXR                 Met-H4
                                    PRMT1            CytC
                                            (arg3)
Inhibition of Arginine Methyltransferase Activity
    Decreases FXR-mediated Transcription



                                                             6E
                                           MTA   6E   MTA
                                                            +MTA
                                 BSEP

                                 β-actin



                      6E   GW
                                             HepG2 cells
  NT   MTA   6E   GW
                     +MTA +MTA             FXR/RXR/PRMT1
Conclusion
    PRMT1 and histone methylation
pathways are implicated in the activation
           of FXR responsive
    genes with biological relevance
          in the homeostasis
     of bile acids and cholesterol
COACTIVATOR COMPLEX RECRUITED
     BY FXR ACTIVATION




     NR   NR
FXR/RXR Transactivation Induced By PRMT1
   Is Enhanced by RXR Ligand 9-CIS RA
                                 HepG2 cells
      Rlu/βgal




                        NT   9-cis   6E    6E     NT   9-cis   6E    6E
                                          9-cis                     9-cis


                 FXR/RXR Is a Permissive Heterodimer.
                     RXR ligand 9-cisRA induces
                      transactivation by PRMT1

More Related Content

What's hot

Auxin proteo controller
Auxin proteo controllerAuxin proteo controller
Auxin proteo controllerYumi Saiki
 
Structure prediction with FAMS for proteins screened critically to autoimmun...
Structure prediction with FAMS for proteins  screened critically to autoimmun...Structure prediction with FAMS for proteins  screened critically to autoimmun...
Structure prediction with FAMS for proteins screened critically to autoimmun...
Y-h Taguchi
 
A new effector pathway links ATM kinase with the DNA damage response
A new effector pathway links ATM kinase with the DNA damage responseA new effector pathway links ATM kinase with the DNA damage response
A new effector pathway links ATM kinase with the DNA damage response
Costas Demonacos
 
Comparative analysis of genome methylation in Thermotogae isolates from deep-...
Comparative analysis of genome methylation in Thermotogae isolates from deep-...Comparative analysis of genome methylation in Thermotogae isolates from deep-...
Comparative analysis of genome methylation in Thermotogae isolates from deep-...
Thomas Haverkamp
 
2015 - Cdk5 promotes DNA replication stress checkpoint activation through RPA...
2015 - Cdk5 promotes DNA replication stress checkpoint activation through RPA...2015 - Cdk5 promotes DNA replication stress checkpoint activation through RPA...
2015 - Cdk5 promotes DNA replication stress checkpoint activation through RPA...Simon Gemble
 
Will_4-13-15_GroupMtng_Final
Will_4-13-15_GroupMtng_FinalWill_4-13-15_GroupMtng_Final
Will_4-13-15_GroupMtng_FinalWilliam Daggett
 
Nc3R\'s Meeting
Nc3R\'s MeetingNc3R\'s Meeting
Nc3R\'s Meeting
Dominic Williams
 
Discovery of Novel Shp2 inhibitors
Discovery of Novel Shp2 inhibitorsDiscovery of Novel Shp2 inhibitors
Discovery of Novel Shp2 inhibitorsLiwei Chen
 
BAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASHBAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASH
Attività scientifica
 
Cancer drug targets 2013
Cancer drug targets 2013Cancer drug targets 2013
Cancer drug targets 2013Elsa von Licy
 
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive  Disease  Week 2017    BAR704   reduces liver fibrosisDigestive  Disease  Week 2017    BAR704   reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
Attività scientifica
 
Development of a high throughput in vitro screening platform to identify nove...
Development of a high throughput in vitro screening platform to identify nove...Development of a high throughput in vitro screening platform to identify nove...
Development of a high throughput in vitro screening platform to identify nove...
Oncodesign
 
Rosloniec_et_al-2009-Molecular_Microbiology.sup-1
Rosloniec_et_al-2009-Molecular_Microbiology.sup-1Rosloniec_et_al-2009-Molecular_Microbiology.sup-1
Rosloniec_et_al-2009-Molecular_Microbiology.sup-1Kamila du Plessis
 
20200219 Shinya Oki
20200219 Shinya Oki20200219 Shinya Oki
20200219 Shinya Oki
KyushuBioinformaticsCommunity
 

What's hot (20)

Auxin proteo controller
Auxin proteo controllerAuxin proteo controller
Auxin proteo controller
 
Structure prediction with FAMS for proteins screened critically to autoimmun...
Structure prediction with FAMS for proteins  screened critically to autoimmun...Structure prediction with FAMS for proteins  screened critically to autoimmun...
Structure prediction with FAMS for proteins screened critically to autoimmun...
 
Mb cell death-apoptosis
Mb cell death-apoptosisMb cell death-apoptosis
Mb cell death-apoptosis
 
A new effector pathway links ATM kinase with the DNA damage response
A new effector pathway links ATM kinase with the DNA damage responseA new effector pathway links ATM kinase with the DNA damage response
A new effector pathway links ATM kinase with the DNA damage response
 
Comparative analysis of genome methylation in Thermotogae isolates from deep-...
Comparative analysis of genome methylation in Thermotogae isolates from deep-...Comparative analysis of genome methylation in Thermotogae isolates from deep-...
Comparative analysis of genome methylation in Thermotogae isolates from deep-...
 
Cristina Clement L08 presentation YI APS 2015 Orlando Florida
Cristina Clement L08 presentation YI APS 2015 Orlando FloridaCristina Clement L08 presentation YI APS 2015 Orlando Florida
Cristina Clement L08 presentation YI APS 2015 Orlando Florida
 
2015 - Cdk5 promotes DNA replication stress checkpoint activation through RPA...
2015 - Cdk5 promotes DNA replication stress checkpoint activation through RPA...2015 - Cdk5 promotes DNA replication stress checkpoint activation through RPA...
2015 - Cdk5 promotes DNA replication stress checkpoint activation through RPA...
 
Mb cardiovascular
Mb cardiovascularMb cardiovascular
Mb cardiovascular
 
Will_4-13-15_GroupMtng_Final
Will_4-13-15_GroupMtng_FinalWill_4-13-15_GroupMtng_Final
Will_4-13-15_GroupMtng_Final
 
SCE Presentation
SCE PresentationSCE Presentation
SCE Presentation
 
Nc3R\'s Meeting
Nc3R\'s MeetingNc3R\'s Meeting
Nc3R\'s Meeting
 
Discovery of Novel Shp2 inhibitors
Discovery of Novel Shp2 inhibitorsDiscovery of Novel Shp2 inhibitors
Discovery of Novel Shp2 inhibitors
 
BAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASHBAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASH
 
Cancer drug targets 2013
Cancer drug targets 2013Cancer drug targets 2013
Cancer drug targets 2013
 
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive  Disease  Week 2017    BAR704   reduces liver fibrosisDigestive  Disease  Week 2017    BAR704   reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
 
Development of a high throughput in vitro screening platform to identify nove...
Development of a high throughput in vitro screening platform to identify nove...Development of a high throughput in vitro screening platform to identify nove...
Development of a high throughput in vitro screening platform to identify nove...
 
Rosloniec_et_al-2009-Molecular_Microbiology.sup-1
Rosloniec_et_al-2009-Molecular_Microbiology.sup-1Rosloniec_et_al-2009-Molecular_Microbiology.sup-1
Rosloniec_et_al-2009-Molecular_Microbiology.sup-1
 
Dc mol testing7oct14
Dc mol testing7oct14Dc mol testing7oct14
Dc mol testing7oct14
 
jm501765v (2)
jm501765v (2)jm501765v (2)
jm501765v (2)
 
20200219 Shinya Oki
20200219 Shinya Oki20200219 Shinya Oki
20200219 Shinya Oki
 

Similar to Boston liver aasld

Dr. Stephen Chanock: Genome-wide Association Studies
Dr. Stephen Chanock: Genome-wide Association StudiesDr. Stephen Chanock: Genome-wide Association Studies
Dr. Stephen Chanock: Genome-wide Association Studies
National Cancer Institute National Cancer Informatics Program
 
Cotsapas ASHG 2011
Cotsapas ASHG 2011Cotsapas ASHG 2011
Cotsapas ASHG 2011
Chris Cotsapas
 
Prof Stefano Fiorucci - Nuclear receptors and lipid metabolism on FXR
Prof Stefano Fiorucci - Nuclear receptors and lipid metabolism on FXRProf Stefano Fiorucci - Nuclear receptors and lipid metabolism on FXR
Prof Stefano Fiorucci - Nuclear receptors and lipid metabolism on FXRAttività scientifica
 
Personalized Medicine Approaches in Oncology
Personalized Medicine Approaches in OncologyPersonalized Medicine Approaches in Oncology
Personalized Medicine Approaches in Oncology
John Theurer Cancer Center at Hackensack University Medical Center
 
Lecture section...Inherited ataxias
Lecture section...Inherited ataxiasLecture section...Inherited ataxias
Lecture section...Inherited ataxias
Professor Yasser Metwally
 
6 RTK signaling MAPK Akt.pdfCell signaling presentation
6 RTK signaling MAPK Akt.pdfCell signaling presentation6 RTK signaling MAPK Akt.pdfCell signaling presentation
6 RTK signaling MAPK Akt.pdfCell signaling presentation
vincentlangat14
 
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
dgotto
 
Thesis discussion andrea robotti
Thesis discussion andrea robottiThesis discussion andrea robotti
Thesis discussion andrea robottiAndrea Robotti
 
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein FamilyDiscriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Chris Southan
 
090630 Ion Cannel Retreat
090630 Ion Cannel Retreat090630 Ion Cannel Retreat
090630 Ion Cannel Retreat
Ralf02
 
MaRS Future of Medicine™ Anticipating a world in which pharmaceutical compani...
MaRS Future of Medicine™ Anticipating a world in which pharmaceutical compani...MaRS Future of Medicine™ Anticipating a world in which pharmaceutical compani...
MaRS Future of Medicine™ Anticipating a world in which pharmaceutical compani...
MaRS Discovery District
 
An approach to describing and analysing bulk biological annotation quality: a...
An approach to describing and analysing bulk biological annotation quality: a...An approach to describing and analysing bulk biological annotation quality: a...
An approach to describing and analysing bulk biological annotation quality: a...
Michael Bell
 
Rho kinase ppt.
Rho kinase ppt.Rho kinase ppt.
Rho kinase ppt.
Biswajit Panda
 
Ligandbiasslideset 120313210323-phpapp02
Ligandbiasslideset 120313210323-phpapp02Ligandbiasslideset 120313210323-phpapp02
Ligandbiasslideset 120313210323-phpapp02
Patty Ahrweiler
 
AJS: a lethal weapon to combat with cancers Treatment of Human Cancers Using...
AJS: a lethal weapon to combat with cancers Treatment of  Human Cancers Using...AJS: a lethal weapon to combat with cancers Treatment of  Human Cancers Using...
AJS: a lethal weapon to combat with cancers Treatment of Human Cancers Using...
gan-navi
 
in vitro radiosenstization of PDAC through FAK inhibition
in vitro radiosenstization of PDAC through FAK inhibition in vitro radiosenstization of PDAC through FAK inhibition
in vitro radiosenstization of PDAC through FAK inhibition
Ahmed Allam
 

Similar to Boston liver aasld (20)

Dr. Stephen Chanock: Genome-wide Association Studies
Dr. Stephen Chanock: Genome-wide Association StudiesDr. Stephen Chanock: Genome-wide Association Studies
Dr. Stephen Chanock: Genome-wide Association Studies
 
Blackmore, Murray
Blackmore, MurrayBlackmore, Murray
Blackmore, Murray
 
Cotsapas ASHG 2011
Cotsapas ASHG 2011Cotsapas ASHG 2011
Cotsapas ASHG 2011
 
Prof Stefano Fiorucci - Nuclear receptors and lipid metabolism on FXR
Prof Stefano Fiorucci - Nuclear receptors and lipid metabolism on FXRProf Stefano Fiorucci - Nuclear receptors and lipid metabolism on FXR
Prof Stefano Fiorucci - Nuclear receptors and lipid metabolism on FXR
 
Personalized Medicine Approaches in Oncology
Personalized Medicine Approaches in OncologyPersonalized Medicine Approaches in Oncology
Personalized Medicine Approaches in Oncology
 
Lecture section...Inherited ataxias
Lecture section...Inherited ataxiasLecture section...Inherited ataxias
Lecture section...Inherited ataxias
 
6 RTK signaling MAPK Akt.pdfCell signaling presentation
6 RTK signaling MAPK Akt.pdfCell signaling presentation6 RTK signaling MAPK Akt.pdfCell signaling presentation
6 RTK signaling MAPK Akt.pdfCell signaling presentation
 
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
 
Thesis discussion andrea robotti
Thesis discussion andrea robottiThesis discussion andrea robotti
Thesis discussion andrea robotti
 
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein FamilyDiscriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
Discriminating Facts from Artefacts in the Secreted Ly-6 Protein Family
 
090630 Ion Cannel Retreat
090630 Ion Cannel Retreat090630 Ion Cannel Retreat
090630 Ion Cannel Retreat
 
MaRS Future of Medicine™ Anticipating a world in which pharmaceutical compani...
MaRS Future of Medicine™ Anticipating a world in which pharmaceutical compani...MaRS Future of Medicine™ Anticipating a world in which pharmaceutical compani...
MaRS Future of Medicine™ Anticipating a world in which pharmaceutical compani...
 
Stam Cell Niche
Stam Cell NicheStam Cell Niche
Stam Cell Niche
 
An approach to describing and analysing bulk biological annotation quality: a...
An approach to describing and analysing bulk biological annotation quality: a...An approach to describing and analysing bulk biological annotation quality: a...
An approach to describing and analysing bulk biological annotation quality: a...
 
Rho kinase ppt.
Rho kinase ppt.Rho kinase ppt.
Rho kinase ppt.
 
Ligandbiasslideset 120313210323-phpapp02
Ligandbiasslideset 120313210323-phpapp02Ligandbiasslideset 120313210323-phpapp02
Ligandbiasslideset 120313210323-phpapp02
 
AJS: a lethal weapon to combat with cancers Treatment of Human Cancers Using...
AJS: a lethal weapon to combat with cancers Treatment of  Human Cancers Using...AJS: a lethal weapon to combat with cancers Treatment of  Human Cancers Using...
AJS: a lethal weapon to combat with cancers Treatment of Human Cancers Using...
 
Dr. Campo MCL
Dr. Campo MCLDr. Campo MCL
Dr. Campo MCL
 
Dr. Campo MCL
Dr. Campo MCLDr. Campo MCL
Dr. Campo MCL
 
in vitro radiosenstization of PDAC through FAK inhibition
in vitro radiosenstization of PDAC through FAK inhibition in vitro radiosenstization of PDAC through FAK inhibition
in vitro radiosenstization of PDAC through FAK inhibition
 

More from Attività scientifica

Microbiota 2019
Microbiota  2019 Microbiota  2019
Microbiota 2019
Attività scientifica
 
Il punto sul microbiota e le malattie umane- Covegno scientifico
Il  punto sul microbiota e le malattie umane- Covegno scientifico Il  punto sul microbiota e le malattie umane- Covegno scientifico
Il punto sul microbiota e le malattie umane- Covegno scientifico
Attività scientifica
 
Microbiota update perugia-
Microbiota  update perugia- Microbiota  update perugia-
Microbiota update perugia-
Attività scientifica
 
Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018
Attività scientifica
 
Portal hypertension and gastrointestinal bleeding
Portal hypertension  and gastrointestinal bleedingPortal hypertension  and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleeding
Attività scientifica
 
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017
Ade 2018 emorragie  Attività didattica integrativa  28 novembre 2017Ade 2018 emorragie  Attività didattica integrativa  28 novembre 2017
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017
Attività scientifica
 
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva  causes  114 serious side effects and 24 deaths according to FDAOcaliva  causes  114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
Attività scientifica
 
Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in  vitro   Metabolomic profile of the probiotic of VSL#3 in  vitro
Metabolomic profile of the probiotic of VSL#3 in vitro
Attività scientifica
 
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Attività scientifica
 
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages  GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
Attività scientifica
 
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Attività scientifica
 
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3   shows metabolic instability Digestive Disease Week 2017 The probiotic VSL#3   shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Attività scientifica
 
NAFLD/NASH - 3 febbraio 2017-
NAFLD/NASH - 3  febbraio 2017-NAFLD/NASH - 3  febbraio 2017-
NAFLD/NASH - 3 febbraio 2017-
Attività scientifica
 
New official web site
New  official web siteNew  official web site
New official web site
Attività scientifica
 
Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer  ddw2016Tgr5 and gastric cancer  ddw2016
Tgr5 and gastric cancer ddw2016
Attività scientifica
 
Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016
Attività scientifica
 
Shp and liver fibrosis ddw 2016
Shp and liver fibrosis  ddw 2016Shp and liver fibrosis  ddw 2016
Shp and liver fibrosis ddw 2016
Attività scientifica
 
Ccr5 and colitis ddw 2016
Ccr5 and  colitis ddw 2016Ccr5 and  colitis ddw 2016
Ccr5 and colitis ddw 2016
Attività scientifica
 
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONSBILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
Attività scientifica
 
Research gate fiorucci citations
Research gate fiorucci citationsResearch gate fiorucci citations
Research gate fiorucci citations
Attività scientifica
 

More from Attività scientifica (20)

Microbiota 2019
Microbiota  2019 Microbiota  2019
Microbiota 2019
 
Il punto sul microbiota e le malattie umane- Covegno scientifico
Il  punto sul microbiota e le malattie umane- Covegno scientifico Il  punto sul microbiota e le malattie umane- Covegno scientifico
Il punto sul microbiota e le malattie umane- Covegno scientifico
 
Microbiota update perugia-
Microbiota  update perugia- Microbiota  update perugia-
Microbiota update perugia-
 
Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018
 
Portal hypertension and gastrointestinal bleeding
Portal hypertension  and gastrointestinal bleedingPortal hypertension  and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleeding
 
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017
Ade 2018 emorragie  Attività didattica integrativa  28 novembre 2017Ade 2018 emorragie  Attività didattica integrativa  28 novembre 2017
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017
 
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva  causes  114 serious side effects and 24 deaths according to FDAOcaliva  causes  114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
 
Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in  vitro   Metabolomic profile of the probiotic of VSL#3 in  vitro
Metabolomic profile of the probiotic of VSL#3 in vitro
 
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
 
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages  GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
 
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
 
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3   shows metabolic instability Digestive Disease Week 2017 The probiotic VSL#3   shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
 
NAFLD/NASH - 3 febbraio 2017-
NAFLD/NASH - 3  febbraio 2017-NAFLD/NASH - 3  febbraio 2017-
NAFLD/NASH - 3 febbraio 2017-
 
New official web site
New  official web siteNew  official web site
New official web site
 
Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer  ddw2016Tgr5 and gastric cancer  ddw2016
Tgr5 and gastric cancer ddw2016
 
Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016
 
Shp and liver fibrosis ddw 2016
Shp and liver fibrosis  ddw 2016Shp and liver fibrosis  ddw 2016
Shp and liver fibrosis ddw 2016
 
Ccr5 and colitis ddw 2016
Ccr5 and  colitis ddw 2016Ccr5 and  colitis ddw 2016
Ccr5 and colitis ddw 2016
 
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONSBILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
 
Research gate fiorucci citations
Research gate fiorucci citationsResearch gate fiorucci citations
Research gate fiorucci citations
 

Recently uploaded

POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 

Recently uploaded (20)

POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 

Boston liver aasld

  • 1. The 2004 AASLD Annual Meeting Speaker Disclosure Slide I have no conflict of interest
  • 2. The Methyl Trasnferase PRMT1 Functions As Co- Activator of FXR/RXR and Regulates Transcription of FXR Responsive Gene In Hepatocytes. Stefano Fiorucci1, Giovanni Rizzo1, Barbara Renga1, Elisabetta Antonelli1, Eleonora Distrutti1, Mark Pruzanski2; Antonio Morelli1, Roberto Pellicciari3 1 Departement of Internal Medicine, Gastrointestinal and Liver Unit and 3 Department of Drug Technology, University of Perugia, Italy 2 Intercept Pharmaceuticals, New York, NY
  • 3. FARNESOID X RECEPTOR (FXR) FXR is a ligand Role of FXR in bile acid biosynthesis activated NR that regulates bile acid synthesis and excretion and lipid homeostasis FXR is expressed in liver,kidney and intestine Target genes: CYP7A1, SHP, BSEP, MRP2, MDR3, I-BABP Mikishima M., et al. Science 1999; 284: 1362-65; Parks DJ., et al. Science 1999; 284: 1365-68 Goodwin B., et al. Molecular cell 2000; 6: 507-515
  • 4. Background FXR is an obligate partner of nuclear RXR (Retinoid X Receptor) In the presence of FXR ligands, the FXR/RXR complex recruits members of the p160 coactivator family that acetylate histones
  • 5. Background In addition to acetylation, histone methylation is critically involved in chromatin remodelling in eukaryotic cells PRMT(Protein aRginine MethylTransferase)-1 is the predominant, if not exclusive, H4 Arg3-methyltransferase in mammalian cells PRMT1 functions as a coactivator for NRs (thyroid, estrogen and androgen receptors..) Kouzarides T. Current Opinion in Genetics & Develop 2002; 12: 198-209
  • 6. FXR Crystal Structure In Complex With 6-ECDCA CO2H FXR -LBD H GW4064 6-ECDCA 150 + Relative Luciferase/βGal CDCA HO OH π 100 50 0 -10 -9 -8 -7 -6 -5 -4 Agonist concentration (Log M) 6- ECDCA Mi L-Z., et al. Molecular Cell 2003; 11:1093-1100
  • 7. Aims Activation of FXR/RXR complex recruits PRMT1 PRMT1 mediates the effects of FXR/RXR ligands on target genes
  • 9. FXR/RXR activation leasds to methylation of Histone 4
  • 10. In vitro methylation 293T cells (kidney fibroblast) were transiently transfected with FXR, RXR and PRMT1 expression vectors and then induced with FXR ligands Cell lysates were Immunoprecipitated with anti-FXR antiboby. The immunoprecipitated were then used for in vitro methylation by incubating them with methyl 3H-methionine followed by SDS page and fluorography
  • 11. FXR/RXR posses H4 specific histone methylation activity 6-ECDCA - + - - + + + In vitro H4 methylation GST- IP: IP anti-: PAS CD3 FXR CD3 FXR PRMT1 anti-FXR - + 6-ECDCA WB: anti FXR WB: anti RXR WT FXR/RXR
  • 12. Is FXR/RXR-induced histone methylation mediated by PRMT1?
  • 13. FXR Interacts In Vivo With PRMT1 6-ECDCA + + - + - WB: PRMT1 (42 KDa) IP: IP: αCD3 α FXR LT 293T cells FXR/RXR/PRMT1 GW4064 + - + - + - WB: PRMT1 (42 KDa) Mks IP: IP: LT α CD3 α FXR 293T cells FXR/RXR/PRMT1
  • 14. HepG2 cells PRMT1 Functions As A Coactivator of FXR/RXR Heterodimer 4000000 DMSO 6-ECDCA * 150000 FXR/RXR/PRMT1 * 3000000 Rlu/ β Gal FXRE-Mut 100000 rlu/β-gal 2000000 * * ** FXR/RXR 1000000 50000 0 0 PRMT1 FXR/RXR FXR/RXR/PRMT1 0 0.1 1 10 100 6-ECDCA (µM)
  • 15. PRMT1 Induces Transcriptional Activation of BSEP FXR/RXR FXR/RXR/PRMT1
  • 16. PRMT1 Induces Transcriptional Activation of SHP FXR/RXR FXR/RXR/PRMT1
  • 17. PRMT1 Enhances FXR Activation of The BSEP Promoter by H4 Methylation Immunochromatin precipitation (ChIP) was used to analyze the promotorial context of FXR responsive gene promoter in HepG2 cells cotransfected with FXR, RXR, PRMT1 expression vectors ChIPs was performed with anti: FXR, PRMT1, dimethyl- H4 (Arg3) and CytC. Immunoprecipitates were analyzed by qRT-PCR to BSEP gene promoter (binds FXR)* Ananthanarayanan M., et al., JBC 2001:276:28857
  • 18. PRMT1 ENHANCES FXR ACTIVATION OF THE BSEP PROMOTER BY H4 METHYLATION. - + - + - + - + 6-ECDCA BSEP Promoter Met-H4 IP anti: FXR PRMT1 CytC (Arg3) HepG2 cells FXR/RXR/PRMT1 IP anti: FXR Met-H4 PRMT1 CytC (arg3)
  • 19. Inhibition of Arginine Methyltransferase Activity Decreases FXR-mediated Transcription 6E MTA 6E MTA +MTA BSEP β-actin 6E GW HepG2 cells NT MTA 6E GW +MTA +MTA FXR/RXR/PRMT1
  • 20. Conclusion PRMT1 and histone methylation pathways are implicated in the activation of FXR responsive genes with biological relevance in the homeostasis of bile acids and cholesterol
  • 21. COACTIVATOR COMPLEX RECRUITED BY FXR ACTIVATION NR NR
  • 22. FXR/RXR Transactivation Induced By PRMT1 Is Enhanced by RXR Ligand 9-CIS RA HepG2 cells Rlu/βgal NT 9-cis 6E 6E NT 9-cis 6E 6E 9-cis 9-cis FXR/RXR Is a Permissive Heterodimer. RXR ligand 9-cisRA induces transactivation by PRMT1